Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases

References

• WHO Expert Consultation on Rabies. Second report. Technical Report Series No. 982. Geneva: World Health Organization; 2013
   Google Scholar
• World Health Organization (WHO). Rabies vaccines, WHO position paper. Weekly Epidemiological Record 2010; 32(85):309-20
   Google Scholar
• WHO Expert Committee on Rabies. Eight report. Technical report series No. 824. Geneva: World Health Organization; 1992.
   Google Scholar
• Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine 2007; 25:7605-9; PMID:17905484; http://dx.doi.org/10.1016/j.vaccine.2007.08.054
   PubMed Web of Science ®Google Scholar
• Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, Lohsoonthorn V, Khawplod P, Tantawichien T. Post exposure rabies Prophylaxis Completed in 1 Week: Preliminary Study. CID 2010; 50:56-60; PMID:19995217; http://dx.doi.org/10.1086/649211
   PubMed Web of Science ®Google Scholar
• Human and dog rabies prevention and control. Report of the WHO/Bill & Melinda Gates foundation consultation. Annecy, France 7–9 October 2009.
   Google Scholar
• Sudarshan MK, Ashwath Narayana DH, Madhusudana SN, Ramesh Holla, Ashwin YA, Gangaboraiah B, Ravish HS. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis. Hum Vaccin Immunotherapeut 2012; 8(8):1077-81; PMID:22699446; http://dx.doi.org/10.4161/hv.20471
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Nicholson KG, Warrell DA, Suntharasamai P, Chanthavanich P, Viravan C, Sinhaseni A, Chiewbambroongkiat MK, Pouradier-Duteil X, Xueref C, et al. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985; 1(8437):1059-62; PMID:2860284
   PubMed Web of Science ®Google Scholar
• Suntharasamai P, Chaiprasithikul P, Wasi C, Supanaranond W, Auewarakul P, Chanthavanich P, Supapochana A, Areeraksa S, Chittamas S, Jittapalapongsa S, et al. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for post exposure prophylaxis. Vaccine 1994; 12(6):508-12; PMID:8036824; http://dx.doi.org/10.1016/0264-410X(94)90308-5
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Premanand N, Ranjini S. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies. Nat Med J India 2001; 14(3):145-7; PMID:11467142
   PubMed Web of Science ®Google Scholar
• Briggs DJ, Banzhoff A, Nicolay U, Dumavibhat B, Tongswas S, Wasi C. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified verocell rabies vaccine. Bulletin of the World Health Organization 2000; 78:683-7
   Google Scholar
• Quiambao BP, Dimaano EF, Ambas C, Davis R, Banzhoff A, Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory confirmed rabies animals. Vaccine 2005; 23:1709-14; PMID:15705476; http://dx.doi.org/10.1016/j.vaccine.2004.09.027
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Ashwathnarayana DH, Anandgiri MS Muhamuda K, Ravi K, Vakil HB, Malerczyk C. Comparison of safety and immunogenecity of purified chick embryo cell vaccine and purified verocell rabies vaccine using the Thai Red Cross intradermal regimen at a dose of 0.1 mL. Hum Vaccin 2006; 2(5):200-4.
   PubMed Web of Science ®Google Scholar
• Arvydas A, Alvydas L, Ligita B, Angelika B, Claudius M. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified verocell rabies vaccine (PVRV) in a four site intradermal schedule (4-0-2-0-1-1): An immunogenic, cost effective and practical regimen. Vaccine 2006; 24(19):4116-21
   PubMed Web of Science ®Google Scholar
• Khawplod P, Wilde H, Sirikwin S, Benjawongkulchai M, Limusanno S, Jaijaroensab W, Chiraguna N, Supich C, Wangroongsarb Y, Sitprija V. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006; 24(16):3084-6; PMID:16494972; http://dx.doi.org/10.1016/j.vaccine.2006.01.051
   PubMed Web of Science ®Google Scholar
• Ravish HS, Veena V, Madhusudana SN, Sudarshan MK, Ashwath Narayana DH, Gangaboraiah, Ashwin BY, Rachana AR, Manjula S.Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis. Hum Vaccin 2014;10(8):2433-7
   Google Scholar
• Sampath G, S N Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, Mohan K, Madhusudhan SK, Ravish HS. Immunogenicity and safety study of Indirab: A verocell based chromatographically purified human rabies vaccine. Vaccine 2010; 28:4086-90; PMID:20403351; http://dx.doi.org/10.1016/j.vaccine.2010.03.064
   PubMed Web of Science ®Google Scholar
• Mahendra BJ, Harish BR, Vinay M. A study of factors influencing compliance of IDRV at ARC of Mandya Institute of Medical Sciences, Mandya. J APCRI 2009; 11(1):18-20
   Google Scholar
• Katie Hampson, Sarah Cleaveland, Deborah Briggs. Evaluation of Cost-Effective Strategies for Rabies Post- Exposure Vaccination in Low-Income Countries. PLoS Neglect Trop Dis 2011; 5(3): e982; PMID:21408121; http://dx.doi.org/10.1371/journal.pntd.0000982
   PubMed Web of Science ®Google Scholar
• Ashwathnarayana DH, Madhusudana SN, Sampath G, Satapathy DM, Mankeshwar R, Ravish HS Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, et al. A comparative study on the safety and immunogenicity of purified duck embryo cell vaccine (PDEV, Vaxirab) with purified chick embryo cell rabies vaccine (PCEC, Rabipur) and purified vero cell rabies vaccine (PVRV, Verorab). Vaccine 2010; 28(1):148-51; PMID:19818720; http://dx.doi.org/10.1016/j.vaccine.2009.09.090
   PubMed Web of Science ®Google Scholar
• Suwansrinon K, Wilde H, Benjavongkulchai M, Banjongkasaena U, Lertjarutorn S, Boonchang S, Suttisri R, Khowplod P, Daviratanasilpa S, Sitprija V. Survival of neutralizing antibody in previously rabies vaccinated subjects: A prospective study showing long lasting immunity. Vaccine 2006; 24:3878-80; PMID:16530893; http://dx.doi.org/10.1016/j.vaccine.2006.02.027
   PubMed Web of Science ®Google Scholar